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What Happens Where the Right and Left Ventricles Meet?*Amit R. Patel, MD,yz Karima Addetia, MDySEE PAGE 1209C ardiac magnetic resonance (CMR) is increas-ingly being used to evaluate patients withpulmonary hypertension (PH). A compre-
hensive CMR study often includes cine imaging to
assess left and right ventricular (RV) size and func-
tion; tissue characterization to identify pathological
processes within the myocardium; magnetic reso-
nance angiography to evaluate the anatomy of the
aorta, pulmonary artery, and systemic/pulmonary
veins; and velocity encoded imaging to quantify
shunt fractions and cardiac output. Such a study,
not only has the potential to differentiate between
different categories of PH, but also provide important
insights into RV function and prognosis. It is increas-
ingly recognized that RV failure secondary to chroni-
cally elevated afterload is often the cause of death in
pulmonary hypertension. A particular strength of
CMR is the assessment of RV size and function. The
complex shape of the right ventricle makes it very
challenging to reproducibly quantify its size and ejec-
tion fraction using conventional imaging modalities
such as echocardiography, whereas these parameters
can reliably be quantiﬁed using CMR because geomet-
ric assumptions about the shape of the ventricle are
not required (1). Several investigators have shown
that RV ejection fraction and RV end-diastolic volume
are predictors of prognosis in individuals with pulmo-
nary hypertension (2,3). Yet others have shown the
importance of parameters which study the function
of the pulmonary arterial bed such as pulmonary
artery distensibility (4).*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
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the prognostic utility of myocardial late gadolinium
enhancement (LGE) in PH. There is growing evidence
that patients with PH, especially if severe and asso-
ciated with increased RV volumes, mass, or decreased
RV ejection fraction on CMR, display a characteristic
pattern of mid-myocardial wall enhancement at the
RV insertion points with or without associated
enhancement of the interventricular septum (3,6–8).One of the ﬁrst descriptions of this ﬁnding was made
in a spectrum of patients with PH including idiopathic
pulmonary arterial hypertension, late correction of
tetralogy of Fallot, and hypertrophic cardiomyopathy
(6). The common denominator in these patients was
the fact that they all had invasively conﬁrmed PH. In
fact, the prevalence of LGE in patients with diagnosed
PH seems to be not insigniﬁcant based on the studies
done so far. Freed et al. (3) showed that 40 of
58 patients with PH had LGE. Blythe et al. (7) and Sanz
et al. (8) studied 25 and 42 patients, respectively, and
found that 23 of 25 and 41 of 42 had LGE. In the cur-
rent study by Swift et al. (5), 135 of 162 consecutive
patients with PH had LGE. That is a sizeable 83% of
treatment-naive patients. Of these patients, 88 of 135
had LGE isolated to the insertion points, and 47 of
135 had LGE that extended into the interventricular
septum. The presence of LGE at the insertion points
has been shown to be sensitive (83%) and speciﬁc
(94%) for the diagnosis of PH (9). Similar results were
reported in this study (5). The presence of LGE in
patients with PH has been previously shown to be
associated with time to clinical worsening (3). The
current study expands on these ﬁndings by demon-
strating that LGE of the insertion points that extends
into the septum is a stronger predictor of mortality on
univariate analysis than just LGE of the insertion
points. The authors also show that other CMR
parameters such as RV end-systolic volume and RV
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1219ejection fraction also predict mortality on univariate
study. However, like others, they were not able
to show that the presence of LGE in PH is an inde-
pendent predictor of mortality.
The mechanism of LGE in PH is poorly understood.
At this time, there is probably enough evidence to
conclude that the presence of LGE in PH is not
secondary to scar or ischemia. It is true that chronic
inducible RV ischemia has been documented in pa-
tients with PH. This is likely secondary to the high RV
systolic pressures and increased myocardial wall
stress leading to impaired coronary perfusion during
systole. There is, however, no evidence of reversible
myocardial ischemia within either the insertion points
or interventricular septum on stress scintigraphy in
patients with PH (10). The RV insertion points are re-
gions that come to bear a considerable amount of
mechanical stress. In PH, these stresses are magniﬁed
because of the remodeling of the right ventricle and
the continued high interchamber pressures, and can
be manifest as paradoxical septal displacement. In
fact, the presence of LGE in the septum has been
associated with paradoxical septal motion (7). One
theory put forth for the explanation of LGE is that it
accumulates in areas of increased mechanical stress,
which in PHwould be the insertion points and septum.
What is not clear in this hypothesis is where the
gadolinium actually accumulates. We know that
gadolinium can accumulate in areas of expanded
extracellular space such as that caused by ﬁbrosis,
protein inﬁltration, and collagen deposition. Bradlow
et al. (11) examined the heart of a patient with idio-
pathic PH who had evidence of RV insertion point LGE
on CMR. They discovered areas of myocardial disarray
and increased collagen and fat deposition between
ﬁber bundles, a ﬁnding that is histologically described
as plexiform ﬁbrosis. They proposed that the archi-
tecture of the RV insertion point and interventricular
septum is exaggerated in PH, because neither myo-
cardial disarray nor the presence of collagen in this
area is abnormal per se, by RV remodeling and shear
forces from the paradoxical motion of the interven-
tricular septum leading to contrast pooling in this area.
They further postulated that this explanation could
account for the mid-myocardial distribution of LGE inpatients with PH and why the quantity of LGE corre-
lates with RV mass and volumes (7,8). Findings in the
current study (5) suggest that patients with LGE that
extends into the septum had larger RV volumes than
those with LGE isolated to the insertion points. The
authors do not comment on whether, in their cohort,
extent of LGE correlated with RV volumes and mass.
Yet another explanation for the LGE (especially when
it is isolated to the RV insertion points) is that it
represents through-plane partial volume effect from
contrast trapping in the acute angles of the right
ventricle where it inserts into the left ventricle.
Because the interventricular septum is on a contin-
uous, and often inverted, curve in individuals with
severe PH and because imaging slices are typically at
least 6 to 10 mm thick, a small amount of contrast-
ﬁlled RV cavity contaminating a voxel that predomi-
nantly includes myocardium near the RV insertion
point would appear completely bright and as if the
contrast were actually within the myocardium.
Regardless of the underlying mechanism of RV inser-
tion point LGE, it is clear that the ﬁnding occurs
commonly in severe PH complicated by signiﬁcant RV
dilation and dysfunction.
One of the challenges in interpreting studies of PH
is that there are several subgroups of pulmonary
hypertension, each with a distinct pathophysiology,
prognosis, and treatment. In this study (5), the
investigators present a brief look at the PH subgroups,
but statistical analysis comparing parameters be-
tween populations was not performed, because of the
limited size of each of the subgroups. But one won-
ders whether in patients with pulmonary arterial
hypertension, where the RV remodels more dramati-
cally, the ﬁnding of LGE would be more common.
Interestingly, nearly 50% of patients with PH as a
result of left heart disease did not have LGE on CMR.
Furthermore, the results of this study indicate that
it must still be determined whether the presence of
LGE in PH should inﬂuence clinical decision making.
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